Quantum BioPharma Files a US Federal Lawsuit Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing 
BC Platforms Launches New Capabilities to Complement its World Leading Clinical and Genomic Data Management Platform
ZURICH and BOSTON, March 28, 2019 /PRNewswire/ -- BC Platforms, a world leader in secure genomic data management and analytics,...
OSF HealthCare Deploys Redox for Better Patient Care
PEORIA, Ill., March 27, 2019 /PRNewswire/ -- A new collaboration between Peoria, Illinois-based OSF HealthCare and Redox, based in Madison, Wisconsin,...
ARMCO Continues Growth With Additional Business Partners And Sales Executives
ATLANTA, March 27, 2019 /PRNewswire/ -- ARMCO Partners, www.armcopartners.com, a leader in healthcare Revenue Cycle and Health Information Management (HIM),...
Completion of Name Change and Consolidation
VANCOUVER, BC / ACCESSWIRE / March 28, 2019 / Canland Health Corp. (formerly, 1155176 B.C. LTD.) (the "Company") is pleased...
Liveyon’s Live ‘Pure-Cast’ Podcast Series Sheds Light on Miseducation in Stem Cell Industry
YORBA LINDA, Calif., March 29, 2019 /PRNewswire/ -- Industry leader Liveyon, LCC is taking on the most controversial topics in...
Vycor Medical Reports Financial Results for the Year Ended December 31st, 2018
BOCA RATON, FL / ACCESSWIRE / March 29, 2018 / Vycor Medical, Inc. (Vycor) (OTCQB: VYCO), a provider of innovative...
ENDRA Life Sciences Reports Initial Findings on First Human TAEUS Feasibility Study of Liver Fat
ANN ARBOR, MI / ACCESSWIRE / March 29, 2019 / ENDRA Life Sciences Inc. (''ENDRA'') (NASDAQ: NDRA), a developer of...
ReShape Lifesciences Announces $2 Million Convertible Note Financing
SAN CLEMENTE, CA / ACCESSWIRE / March 29, 2019 / ReShape Lifesciences Inc. (OTCQB: RSLS), a developer of minimally invasive...
U.S. FDA Acknowledges Receipt of Intellipharmaceutics’ Resubmission of Oxycodone ER New Drug Application, Deems it a Complete Response, and Designates August 28, 2019 as Goal Date for Review
TORONTO, ON / ACCESSWIRE / March 29, 2019 / Intellipharmaceutics International Inc. (OTCQB: IPCIF and TSX: IPCI) ("Intellipharmaceutics" or the...
Milestone Scientific Schedules 2018 Year-End Earnings Conference Call
LIVINGSTON, NJ / ACCESSWIRE / March 29, 2019 / Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized...
Nexien BioPharma to Present at The MicroCap Conference Spring Investor Summit on Tuesday, April 2nd
DENVER, CO / ACCESSWIRE / March 28, 2019 / Nexien BioPharma, Inc. ("Nexien" or the "Company") (OTCQB: NXEN), a next...
Hypur Ventures Launches New $500MM Cannabis Fund
Venture capital group announces the launch of its new fund, Hypur Ventures II, that will invest up to $500MM into...
Cova is the Vital Tech Company Behind Ontario Cannabis Stores Opening April 1st
VANCOUVER, BC / ACCESSWIRE / March 28, 2019 / Cova is the point-of-sale (POS) solution of choice for nearly every...
La Vida Verde, Inc. Signs Distribution Deal with Driven Deliveries
DENVER, CO / ACCESSWIRE / March 28, 2019 / International Cannabrands Inc. (CSE: JUJU) (the "Company") is pleased to announce...
VistaGen Therapeutics Receives Australian Patent for Treatment of Depression with AV-101
SOUTH SAN FRANCISCO, CA / ACCESSWIRE / March 28, 2019 / VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing...
GeneNews Launches First Telehealth Initiative for Patient Directed Testing
Company to Capitalize on $16.7 Billion Telehealth Market by Offering Patient Directed Testing Through an Independent Provider Network TORONTO, ON...
Oncolytics Biotech (R) Announces a Publication Highlighting Synergistic Effect of Pelareorep with a Proteasome Inhibitor in Preclinical Models of Multiple Myeloma
- Combination Synergistic Even in Cells That Have Developed Resistance to Bortezomib - Article Published in the March 12 Edition...
Heat Biologics Reports 2018 Results and Provides Corporate Update
Recently announced interim HS-110 Phase 2 data demonstrating survival benefit in patients with ‘cold' tumors (CD8+ TILs < 10% at...
Jaguar Health Issues Regulatory Update Regarding Potential Follow-on Indication for Mytesi
SAN FRANCISCO, CA / ACCESSWIRE / March 28, 2019 / Jaguar Health, Inc. (NASDAQ: JAGX) ("Jaguar" or the "Company"), a...
EVOTEC AG FISCAL YEAR 2018 RESULTS: ACCELERATED GROWTH AND STRONG LONG-TERM OUTLOOK
- EXCELLENCE IN SCIENCE, PARTNERED DRUG DISCOVERY & DEVELOPMENT, ACQUISITIONS, AND UNIQUE PLATFORM TECHNOLOGIES LEAD TO STRONG GROWTH MOMENTUM -...